DJIA 18,098.31 -105.06 -0.58%
NASDAQ 4,969.85 -10.05 -0.20%
S&P 500 2,097.92 -9.86 -0.47%
market minute promo

76.50 0.88 (1.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CRL $76.50 1.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $75.50
Previous Close $75.62
Daily Range $75.33 - $76.65
52-Week Range $49.60 - $77.17
Market Cap $3.6B
P/E Ratio 28.01
Dividend (Yield) $0.00 (0.0%)
Volume 293,729
Average Daily Volume 461,178
Current FY EPS $3.60

Sector

Healthcare

Industry

Drug Makers

Charles River Laboratories (CRL) Description

Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. Website: http://www.criver.com/

News & Commentary Rss Feed

Charles River Laboratories International Beats Analyst Estimates on EPS

Just the facts, Fool.

Health Care Sector Update for 03/02/2015: PCRX, ISIS, XLRN

Insider Trading Alert - DATA, GM And CRL Traded By Insiders

Insider Trading Alert - CCF, EPAM And CRL Traded By Insiders

Charles River Laboratories International's (CRL) CEO James Foster on Q4 2014 Results - Earnings Call

Charles River Laboratories International's (CRL) CEO James Foster on Q4 2014 Results - Earnings Call Transcript

Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog

Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog

Health Care Sector Update for 02/11/2015: CRL,HTBX,DCTH

Earnings Reaction History: Charles River Laboratories, 100.0% Follow-Through Indicator, 2.4% Sensiti

Earnings Reaction History: Charles River Laboratories, 100.0% Follow-Through Indicator, 2.4% Sensitive

Jim Cramer's Top Stock Picks: MNST ESPR CRL

Cramer's Mad Money: Dogs And Cats (1/14/15)

Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog

Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog

See More CRL News...

CRL's Top Competitors

CRL $76.50 (1.16%)
Current stock: CRL
TMO $128.89 (-0.65%)
Current stock: TMO
ILMN $192.63 (-1.74%)
Current stock: ILMN
WAT $120.21 (0.57%)
Current stock: WAT